NCT00569764View on ClinicalTrials.gov

Effect on Metabolic Parameters of Abilify in SPR

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2007

Study Completion Date

October 31, 2009

Conditions
SchizophreniaMetabolic Syndrome
Trial Locations (2)

039-757

RECRUITING

Seoul National Hospital, Seoul

139-757

RECRUITING

Seoul National Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Seoul National Hospital

OTHER_GOV